A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma

被引:0
|
作者
Horvat, Natally [1 ]
Andrieu, Pamela Causa [1 ]
Meier, Andreas [2 ]
Ji, Xinge [3 ]
Lakhman, Yulia [1 ]
Soslow, Robert [4 ]
Allison, Douglas [4 ]
Gangai, Natalie [1 ]
Rodriguez, Lee [1 ]
Kattan, Michael W. [3 ]
Chi, Dennis S. [5 ]
Hricak, Hedvig [1 ,6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA
[2] Univ Hosp Zurich, Dept Radiol, Ramistr 100, CH-8091 Zurich, Switzerland
[3] Cleveland Clin, Dept Quantitat Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, 1275 York Ave, New York, NY 10065 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Radiol, 417 E 68th St,Room Z-2064, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
Ovarian neoplasms; Nomograms; Multidetector computed tomography; COMPUTED-TOMOGRAPHY; FROZEN-SECTION; CANCER; STAGE; PROGNOSIS; SURVIVAL; LYMPHADENECTOMY; ENDOMETRIOSIS; ASSOCIATION; RECURRENCE;
D O I
10.1016/j.ygyno.2023.06.579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. To evaluate clinical, laboratory, and radiological variables from preoperative contrast-enhanced computed tomography (CECT) for their ability to distinguish ovarian clear cell carcinoma (OCCC) from nonOCCC and to develop a nomogram to preoperatively predict the probability of OCCC.Methods. This IRB-approved, retrospective study included consecutive patients who underwent surgery for an ovarian tumor from 1/1/2000 to 12/31/2016 and CECT of the abdomen and pelvis & LE;90 days before primary debulking surgery. Using a standardized form, two experienced oncologic radiologists independently analyzed imaging features and provided a subjective 5-point impression of the probability of the histological diagnosis. Nomogram models incorporating clinical, laboratory, and radiological features were created to predict histological diagnosis of OCCC over non-OCCC. Results. The final analysis included 533 patients with surgically confirmed OCCC (n = 61) and non-OCCC (n = 472); history of endometriosis was more often found in patients with OCCC (20% versus 3.6%; p < 0.001), while CA-125 was significantly higher in patients with non-OCCC (351 ng/mL versus 70 ng/mL; p < 0.001). A nomogram model incorporating clinical (age, history of endometriosis and adenomyosis), laboratory (CA-125) and imaging findings (peritoneal implant distribution, morphology, laterality, and diameter of ovarian lesion and of the largest solid component) had an AUC of 0.9 (95% CI: 0.847, 0.949), which was comparable to the AUCs of the experienced radiologists' subjective impressions [0.8 (95% CI: 0.822, 0.891) and 0.9 (95% CI: 0.865, 0.936)].Conclusions. A presurgical nomogram model incorporating readily accessible clinical, laboratory, and CECT variables was a powerful predictor of OCCC, a subtype often requiring a distinctive treatment approach. & COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [21] A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer
    Yunming Xie
    Hongguang Zhao
    Yan Guo
    Fanyang Meng
    Xiangchun Liu
    Yiying Zhang
    Xiaochen Huai
    Qianting Wong
    Yu Fu
    Huimao Zhang
    European Radiology, 2021, 31 : 6030 - 6038
  • [22] Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
    Kwon, Byung Su
    Jeong, Dae Hoon
    Byun, Jung Mi
    Lee, Tae Hwa
    Choi, Kyung Un
    Song, Yong Jung
    Suh, Dong Soo
    Kim, Ki Hyung
    JOURNAL OF CANCER, 2018, 9 (07): : 1127 - 1134
  • [23] Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
    Hyung, Kim Ki
    Hyeongjun, Hyeong Jun Yoon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 100 - 100
  • [24] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Ackroyd, Sarah A.
    Arguello, David
    Ramos, Pilar
    Mahdi, Haider
    ElNaggar, Adam
    Winer, Ira
    Holloway, Rob
    Krivak, Thomas
    Jones, Nathaniel
    Turner, Valerie Galvan
    Herzog, Thomas
    Chu, Christina
    Brown, Jubilee
    Mantia-Smaldone, Gina
    GYNECOLOGIC ONCOLOGY, 2023, 169 : 164 - 171
  • [25] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Mantia-Smaldone, G. M.
    Arguello, D.
    Mahdi, H.
    ElNaggar, A. C.
    Winer, I.
    Holloway, R. W.
    Krivak, T. C.
    Jones, N. L.
    Galvan-Turner, V.
    Herzog, T. J.
    Chu, C.
    Brown, J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 175 - 175
  • [26] Ovarian clear cell carcinoma in Cowden Syndrome
    Yauy, K.
    Imbert-Bouteille, M.
    Bubien, V.
    Lindet-Bourgeois, C.
    Rathat, G.
    Perrochia, H.
    MacGrogan, G.
    Bessis, D.
    Tinat, J.
    Baert-Desurmont, S.
    Blanluet, M.
    Vande Perre, P.
    Baudry, K.
    Pujol, P.
    Corsini, C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1558 - 1559
  • [27] Leiomyosarcoma with Synchronous Clear Cell Ovarian Carcinoma
    Rettenmaier, Mark
    Epstein, Howard D.
    Abaid, Lisa N.
    Bechtol, Karen A.
    Goldstein, Bram H.
    ONKOLOGIE, 2010, 33 (12): : 695 - 697
  • [28] Tumor heterogeneity in ovarian clear cell carcinoma
    Huang, Ruby Yun-Ju
    CANCER RESEARCH, 2024, 84 (05)
  • [29] Translational genomics of ovarian clear cell carcinoma
    Khalique, Saira
    Lord, Christopher J.
    Banerjee, Susana
    Natrajan, Rachael
    SEMINARS IN CANCER BIOLOGY, 2020, 61 : 121 - 131
  • [30] The unique metabolome of clear cell ovarian carcinoma
    Ji, Jennifer X.
    Hoang, Lien N.
    Cochrane, Dawn R.
    Lum, Amy
    Senz, Janine
    Farnell, David
    Tessier-Cloutier, Basile
    Huntsman, David G.
    Geltink, Ramon I. Klein
    JOURNAL OF PATHOLOGY, 2024, 264 (02): : 160 - 173